Ursus S.A. (URS) Financials Nov 17, 2014, 12:00

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Ursus S.A. (URS) Financials Nov 17, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Ursus S.A.


Fiscal year is January-December. All values PLN millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 107.15M 122.83M 172.36M 227.37M 168.04M
Cost of Goods Sold (COGS) incl. D&A 91.77M 106.09M 146.66M 192.55M 151.7M
COGS excluding D&A 86.43M 100.72M 141.21M 186.49M 145.1M
Depreciation & Amortization Expense 5.34M 5.38M 5.45M 6.05M 6.6M
Depreciation 4.58M - - 4.81M -
Amortization of Intangibles 757,000 - - 1.24M -
Gross Income 15.38M 16.74M 25.7M 34.83M 16.34M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 15.62M 20.96M 24.85M 32.23M 35.42M
Research & Development 0 0 - - -
Other SG&A 15.62M 20.96M 24.85M 32.23M 35.42M
Other Operating Expense 1.22M 559,000 216,000 570,000 1.7M
Unusual Expense (302,000) 130,000 (800,000) (3.85M) 206,000
EBIT after Unusual Expense 302,000 (130,000) 800,000 3.85M (206,000)
Non Operating Income/Expense 2.65M 7.75M 372,000 773,000 57,000
Non-Operating Interest Income 19,000 250,000 1.67M 575,000 38,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 1.35M 1.63M 2.49M 2.72M 4.1M
Gross Interest Expense 1.35M 1.63M 2.49M 2.72M 4.1M
Interest Capitalized - 0 0 0 0
Pretax Income 167,000 1.46M 980,000 4.5M (24.98M)
Income Tax 491,000 785,000 (338,000) 702,000 (2.54M)
Income Tax - Current Domestic - 27,000 0 0 0
Income Tax - Current Foreign - 0 - 0 0
Income Tax - Deferred Domestic - 758,000 (338,000) 702,000 (2.54M)
Income Tax - Deferred Foreign - 0 - - -
Income Tax Credits - 0 - 0 0
Equity in Affiliates (451,000) (42,000) 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (775,000) 635,000 1.32M 3.8M (22.44M)
Minority Interest Expense 0 226,000 107,000 (1.81M) 33,000
Net Income (775,000) 409,000 1.21M 5.61M (22.47M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (775,000) 409,000 1.21M 5.61M (22.47M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (775,000) 409,000 1.21M 5.61M (22.47M)
EPS (Basic) (0.03) 0.02 0.05 0.25 (0.86)
Basic Shares Outstanding 24.03M 24.03M 24.03M 22.18M 26.18M
EPS (Diluted) (0.03) 0.02 0.05 0.21 (0.86)
Diluted Shares Outstanding 24.03M 24.03M 24.03M 26.18M 26.18M
EBITDA 3.88M 601,000 6.08M 8.08M (14.17M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 13

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 131

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 85

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 130

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 53

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 28

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 19

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 35

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 196

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

Securities Fraud Investigation Casts Shadow on Driven Brands

Updated Category News Views 331

The Unfolding Drama Surrounding Driven Brands Out of nowhere, the waters are getting choppy for Driven Brands Holdings, and it’s not just a casual dip; more like a tsunami warning. Ademi LLP is cranking up the heat with an investigation into possible securities fraud that’s got investors scratching their heads and probably running for cover. What’s the Big Deal?...

Continue Reading
Info-Tech Research Group Expands Focus in Asia-Pacific Markets

Updated Category News Views 292

Info-Tech Research Group Expands Its Global Footprint Info-Tech Research Group has recently expanded its global presence by launching a new office in Singapore while significantly ramping up investments in New Zealand. This strategic move enables the firm to provide more localized, outcome-driven support to IT leaders throughout Southeast Asia and the Australia-New...

Continue Reading
Laramide Resources' Strategic Exploration Plans in Kazakhstan

Updated Category News Views 144

Exploration Drilling Plans by Laramide Resources Laramide Resources Ltd., a leading organization in uranium exploration, has identified multiple promising targets within its Chu-Sarysu Project. This initiative is set to take place in a mineral-rich area renowned for its potential to yield significant deposits of uranium and other valuable minerals like rare earth elements...

Continue Reading
Stravito Unveils AI Personas for Accelerated Market Insights

Updated Category News Views 311

Stravito Introduces AI Personas for Enhanced Market Positioning Stravito supports brands in rapidly validating their ideas using advanced AI technology. In a dynamic market environment, Stravito has launched an initiative designed to drastically improve the speed and reliability of idea testing for brands. This revolutionary tool, known as Stravito AI Personas, transforms...

Continue Reading
Duni Introduces Innovative Take-Away Series Boosting Sustainability

Updated Category News Views 245

Duni Introduces Innovative Take-Away Series Boosting Sustainability Duni is excited to unveil a fresh series of take-away packaging that represents a significant leap towards sustainability. The company has developed new packaging solutions that feature a grey plastic base, which can significantly enhance recycling efforts compared to traditional black plastic. This move...

Continue Reading